Liposomal DNA vectors for cystic fibrosis gene therapy. Current applications, limitations, and future directions

This publication has 47 references indexed in Scilit:

• Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
  New England Journal of Medicine, 1994
• Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations
  Human Genetics, 1994
• Efficacy and Safety of Short-term Administration of Aerosolized Recombinant Human Deoxyribonuclease in Patients with Cystic Fibrosis
  American Review of Respiratory Disease, 1993
• The changing epidemiology of cystic fibrosis
  The Journal of Pediatrics, 1993
• Cystic fibrosis: molecular biology and therapeutic implications
  Science, 1992
• Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study
  Published by American Medical Association (AMA) ,1992
• A Preliminary Study of Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis
  New England Journal of Medicine, 1992
• Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
  Science, 1989
• Identification of the Cystic Fibrosis Gene: Genetic Analysis
  Science, 1989
• Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
  Science, 1989